Needle free injection system provides solution of introducing several drugs into the host body without piercing the skin with a hypodermic needle. Needle free drug delivery devices are used worldwide by diabetes patients to administer insulin in their bodies. Increasing cases of chronic diseases such as Dengue, AIDS, and Hepatitis among others have also grown globally. Therefore, the steady growth in chronic diseases has also added to the overall demand for needle free drug delivery devices majorly in the developed and developing countries such as US, Germany, Japan, and China among others. Increasing prevalence’s of chronic diseases such as diabetes, hypertension and cancer, would further drive the global needle free drug delivery device market. According to the WHO, Cancer is one of the leading cause of deaths across the globe. In 2018, 9.6 million deaths occurred due to Cancer. According to the National Cancer Institute, an estimated 1,735,350 new cases of Cancer are diagnosed in the United States and 609,640 people died from the disease in 2018. Needle-free injection offers an advance and effective route for administration drugs without pain.
Also Read: http://www.marketwatch.com/story/insights-on-needle-free-drug-deliv...
Adding further, rising demand to prevent and minimize the effect of needle-stick injuries are also projected to drive the overall demand for the needle free drug delivery devices. Needlestick and sharp injuries can result in the transmission of infectious diseases particularly bloodborne viruses such as HIV, hepatitis B and hepatitis C, among others. The escalation of producing and modeling of the needle free drug delivery devices is expanding due to the inclination of population towards the use of easy, safe and home care drug delivery medical devices. The needle free drug delivery products can be classified based on type such as self-injectors, needle-free injectors and auto-injectors. The needle technology used in this market includes pen-needle and micro-needle. The micro-needle patches have some economic and practical restraints.
Also Read: http://www.marketwatch.com/story/fabric-care-product-market-researc...

Owing to the substantial promotional packages of government plans, the needle-free drug delivery system market is anticipated to propel in the years to come. The global needle free drug delivery market is expected to grow at a CAGR of 10% during the forecast period of 2018- 2025, to reach a market size of US$ billion in 2025. Based on the products prefilled, needle-free injection system dominates the market with the revenue share of in 2018. Fillable needle-free injection system was the second most preferred product category available in the market. Based on technology, jet injectors dominated the market in 2018. Jet injectors technology segment is expected to grow at a CAGR of during the forecast period 2018-2025 to reach a market size of US$ billion by 2025. However, transdermal drug delivery technology system is expected to witness highest CAGR growth during the analyzed period. Insulin delivery, vaccinations, pediatric injections and pain management are the major application of needle free drug delivery system, insulin delivery being the most prominent application of the technology, owing to the increased prevalence’s of diabetes in developed as well as developing countries.
In addition, needle free drug devices are segmented by types of injection methods. The system is designed to inject drug into skin, tissues and muscles using solid and liquid dosages. The liquid injections are expected to grow at the highest rate during the forecast period 2018-2025. Apart from this, Powder Injections constitute the second largest market. Furthermore, needle-free drug devices use power sources such as spring load jet Injector system, gas powdered jet injector and battery powdered jet injector system. The gas powdered jet injector system holds major share in the market with the revenue share of in 2018.
Also Read: http://www.marketwatch.com/story/folding-and-packing-machine-market...
List OF CONTENTS AND TABLES:
1. MARKET INTRODUCTION
1.1 Market Definition 12
1.2 Objective of the Study 12
1.3 Limitation 12
1.4 Stakeholders 13
1.5 Currency used in the Report 13
2. RESEARCH METHODOLOGY OR ASSUMPTION 14
2.1 Research Methodology for Global Needle Free Drug Delivery Devices Market 14
2.1.1 Main objective of the Needle Free Drug Delivery Devices Market Study 15
3. REGULATORY FRAMEWORK AND KEY DEVELOPMENT 16
3.1 General Overview 16
3.1.1 North America 16
3.1.2 Europe 17
4. INDUSTRY PERFORMANCE 18
5. EXECUTIVE SUMMARY 20
6. MARKET OVERVIEW 23
6.1 Introduction 23
6.2 Market Dynamics 24
6.2.1 Market Trend & Drivers 24
6.2.2 Rising Prevalence of Chronic and Lifestyle Diseases 24
6.2.3 Inclination Towards Self Administration of Drugs 26
6.2.4 Growing Technological Advancements in the Devices 27
6.3 Market Challenges 27
6.3.1 Ambiguity in the Specifications of Needle Free Devices 27
6.3.2 Limitations associated with Micro Needle Patches 28
6.4 Market Opportunities 28
6.4.1 Increase in the number of start-ups and Investments 28
6.4.2 Growing Adoption in Emerging Countries of Asia-Pacific Region 30
7. KEY MARKET INDICATORS 31
7.1 General Overview 31
7.1.1 Demand and Supply Side Analysis 31
7.1.1.1 Top Winning Strategies 32
7.1.1.1.1 Top Product launches 32
7.1.1.1.2 Top Business Expansions & Investments 33
7.1.1.1.3 Top Acquisition and Collaborations 34
7.1.2 Needle-free injection technology manufacturing process value chain 35
8. MARKET INSIGHTS BY PRODUCT TYPE (2018-25) 37
8.1 General Overview 37
8.1.1 Prefilled needle-free injection systems 38
8.1.2 Fillable needle-free injection systems 39
9. MARKET INSIGHTS BY TECHNOLOGY (2018-25) 41
9.1 General Overview 41
9.1.1 Jet Injectors 42
9.1.2 Transdermal Drug Delivery Systems 43
9.1.3 Inhaler Technology 44
10. MARKET INSIGHTS BY APPLICATION TYPE (2018- 2025) 46
10.1 General Overview 46
10.1.1 Insulin Delivery 47
10.1.2 Vaccination 48
10.1.3 Pediatric Injections 49
10.1.4 Pain Management 50
11. MARKET INSIGHTS BY INJECTION METHODS 51
11.1 General Overview 51
11.1.1 Powder injections 52
11.1.2 Liquid injections 53
11.1.3 Depot or Projectile Injection 54
12. MARKET INSIGHTS BY SOURCE POWER 55
12.1 General Overview 55
12.1.1 Spring Loaded Jet Injector 56
12.1.2 Gas Powered Jet Injector 57
12.1.3 Battery Powered Jet Injector 58
13. MARKET INSIGHTS BY REGION 59
13.1 General Overview 59
13.1.1 North America Needle-Free Drug Delivery Market (2018-2025) 60
13.1.1.1 North America Needle Free Drug Delivery Market, by Product 62
13.1.1.2 North America Needle-Free Drug Delivery Market, by Technology 62
13.1.1.3 North America Needle-Free Drug Delivery Device Market, by Application 63
13.1.1.4 North America Needle-Free Drug Delivery Market, by Injection Method 63
13.1.1.5 North America Needle Free Drug Delivery Device Market by, Source of Power 64
13.1.2 Europe Needle-Free Drug Delivery Device Market (2018-2025) 64
13.1.2.1 Europe Needle-Free Drug Delivery Device Market, by Product 68
13.1.2.2 Europe Needle-Free Drug Delivery Device Market, by Technology 68
13.1.2.3 Europe Needle-Free Drug Delivery Device Market, by Application 69
13.1.2.4 Europe Needle Free Drug Delivery Device Market, by Injection Method 69
13.1.2.5 Europe Needle-Free Drug Delivery Device Market, by Source of Power 70
13.1.3 Asia Pacific Needle-Free Drug Delivery Device Market (2018-2025) 70
13.1.3.1 Asia Pacific Needle-Free Drug Delivery Device Market, by Product 74
13.1.3.2 Asia Pacific Needle-Free Drug Delivery Device Market, by Technology 74
13.1.3.3 Asia Pacific Needle Free Drug Delivery Device Market, by Application 75
13.1.3.4 Asia Pacific Needle-Free Drug Delivery Device Market, by Injection Method 75
13.1.3.5 Asia Pacific Needle-Free Drug Delivery Device Market, by Source of Power 76
13.1.4 Rest of World Needle-Free Drug Delivery Device Market (2018-2025) 76
13.1.4.1 RoW Needle-Free Drug Delivery Device Market, by Product 78
13.1.4.2 RoW Needle-Free Drug Delivery Device Market, by Technology 78
13.1.4.3 RoW Needle-Free Drug Delivery Device Market, by Application 79
13.1.4.4 RoW Needle Free Needle-Free Device Market, by Injection Method 79
13.1.4.5 RoW Needle-Free Drug Delivery Device Market by Source of Power 80
14. COMPETITIVE SCENARIO 81
14.1 Porter’s Five forces analysis 81
14.1.1 Bargaining power of Buyer 81
14.1.2 Bargaining power of Supplier 82
14.1.3 The threat of new entrants 82
14.1.4 Availability of Substitute 83
14.1.5 Industry Rivalry 83
14.2 Global Needle-Free Drug Delivery Market Share Analysis, 2017 84
15. COMPANY PROFILES 85
15.1 Antares Pharma, Inc. 85
15.1.1 Key Facts 85
15.1.2 Business Description 85
15.1.3 Key Product/Services Offerings 86
15.1.4 SWOT Analysis 87
15.1.5 Key Financials 87
15.1.6 Recent Developments 89
15.1.7 Funding 89
15.2 Consort Medical 90
15.2.1 Key Facts 90
15.2.2 Business Description 90
15.2.3 Key Product/Services Offerings 91
15.2.4 SWOT Analysis 92
15.2.5 Key Financials 92
15.2.6 Revenue Split 93
15.2.7 Recent Developments 94
15.3 Crossject Société Anonyme 95
15.3.1 Key Facts 95
15.3.2 Business Description 95
15.3.3 SWOT Analysis 96
15.3.4 Recent Developments 96
15.3.5 Funding 96
15.4 Inovio Pharmaceuticals 97
15.4.1 Key Facts 97
15.4.2 Business Description 97
15.4.3 SWOT Analysis 99
15.4.4 Key Financials 100
15.4.5 Revenue Split 101
15.4.6 Recent Developments 101
15.4.7 Funding 101
15.5 Injex Pharma 102
15.5.1 Key Facts 102
15.5.2 Business Description 102
15.5.3 Key Product/Services Offerings 102
15.5.4 SWOT Analysis 103
15.6 Medical International Technology 104
15.6.1 Key Facts 104
15.6.2 Business Description 104
15.6.3 Key Product/Services Offerings 105
15.6.4 SWOT Analysis 105
15.6.5 Key Financials 106
15.6.6 Recent Developments 107
15.7 Zosano Pharma 108
15.7.1 Key Facts 108
15.7.2 Business Description 108
15.7.3 Key Product/Services Offerings 109
15.7.4 SWOT Analysis 109
15.7.5 Key Financials 110
15.7.6 Recent Developments 111
15.8 Valeritas 112
15.8.1 Key Facts 112
15.8.2 Business Description 112
15.8.3 Key Product/Services Offerings 113
15.8.4 SWOT Analysis 113
15.8.5 Key Financials 114
15.8.6 Revenue Split 115
15.8.7 Recent Developments 115
15.8.8 Funding 115
15.9 3M 116
15.9.1 Key Facts 116
15.9.2 Business Description 116
15.9.3 Key Product/Services Offerings 117
15.9.4 SWOT Analysis 118
15.9.5 Key Financials 118
15.9.6 Revenue Split 119
15.9.7 Recent Developments 120
15.9.8 Funding 120
15.10 PharmaJet 121
15.10.1 Key Facts 121
15.10.2 Business Description 121
15.10.3 Key Product/Services Offerings 122
15.10.4 SWOT Analysis 122
15.10.5 Recent Developments 123
15.10.6 Funding 123FIG. 1 Research Methodology for Global Needle Free Drug Delivery Devices Market 14
FIG. 2 Global Countries with most Adults Living with Diabetes, 2017 20
FIG. 3 Global Needle Free Drug Delivery Device Market 2019-2025 (US$ Million) 21
FIG. 4 Facts about Chronic Disease in the US, 2016 25
FIG. 5 Frequency of Needle Stick Injuries, by Devices 25
FIG. 6 Process for Self-Administration of Medicines (SAMS) 26
FIG. 7 Global Top Country, by Start-Up County 2017 29
FIG. 8 Global Funding, by Region 2016 & 2017 (US$ billion) 29
FIG. 9 Health Expenditure Per Capita in Asia-Pacific, by Country 2015 (USD PPP) 30
FIG. 10 Needle-free Injection Technology Manufacturing Process 35
FIG. 11 Global Needle-Free Drug Delivery Device Market Share, by Product Type, 2018 & 2025 (%) 37
FIG. 12 Global Needle-Free Drug Delivery Device Market, by Product 2018-25 (US$ Million) 37
FIG. 13 Global Needle-Free Drug Delivery Device Market Share by Technology, 2018 & 2025 (%) 41
FIG. 14 Global Needle-Free Drug Delivery Device Market, by Technology, 2018-25 (US$ Million) 41
FIG. 15 Global Needle-Free Drug Delivery Device Market Share, by Application, 2018 & 2025 (%) 46
FIG. 16 Global Needle-Free Drug Delivery Device Market by Application, 2018-25 (US$ Million) 46
FIG. 17 Global Needle-Free Drug Delivery Device Market Share by Injection Method, 2018 & 2025 (%) 51
FIG. 18 Global Needle-Free Drug Delivery Device Market by Injection method, 2018-25 (US$ Million) 51
FIG. 19 Global Needle-Free Drug Delivery Device Market Share by Source Power, 2018 & 2025 (%) 55
FIG. 20 Global Needle-Free Drug Delivery Device Market by Source of Power, 2018-25 (US$ Million) 55
FIG. 21 Global Needle-Free Drug Delivery Device Market Share by Region, 2018 & 2025 (%) 59
FIG. 22 Global Needle-Free Drug Delivery Device Market by Application, 2018-25 (US$ Million) 59
FIG. 23 Y-o-Y Growth rate of US Healthcare Expenditure (2011-2016), % 60
FIG. 24 Number and % of U.S. Population with Diagnosed Diabetes (2006-2015) 61
FIG. 25 Estimated age-adjusted prevalence of diagnosed diabetes by race/ethnicity and sex among adults aged ≥18 US, 2013–2015 61
FIG. 26 Europe % of population over 65 years old, by Country 2017 65
FIG. 27 Number of people with diabetes in EU28, 2000 and 2017 65
FIG. 28 Europe % of Adult population with Diabetes, by Country 2017 66
FIG. 29 Estimated Incidence rate for all Cancers in Europe, by country, 2018 67
FIG. 30 HIV Prevalence in Asia-Pacific % of Population, by Country 2017 72
FIG. 31 Asia-Pacific Medical Equipment Market US$ Billion (2015-2018) 72
FIG. 32 Ratio of people aged 15-64 to people aged over 65 years in Asia-Pacific, 2015 and 2050 73
FIG. 33 Porter’s Five forces analysis of Global Needle-Free Drug Delivery Device 81
FIG. 34 Patent count of Smart Drug Delivery System 84
FIG. 35 Antares Pharma Inc. SWOT Analysis 87
FIG. 36 Key Financials of Antares Pharma Inc. 87
FIG. 37 Antares Pharma Inc. Revenue Split, 2018 88
FIG. 38 Consort Medical SWOT Analysis 92
FIG. 39 Key Financials of Consort Medical 92
FIG. 40 Consort Medical Revenue Split, 2017 93
FIG. 41 Crossject Société Anonyme SWOT Analysis 96
FIG. 42 Inovio Pharmaceuticals SWOT Analysis 99
FIG. 43 Key Financials of Inovio Pharmaceuticals 100
FIG. 44 Inovio Pharmaceuticals Revenue Split, 2018 101
FIG. 45 Injex Pharma, SWOT Analysis 103
FIG. 46 Medical International Technology, SWOT Analysis 105
FIG. 47 Key Financials of Medical International Technology 106
FIG. 48 Medical International Technology Revenue Split, 2018 107
FIG. 49 Zosano Pharma SWOT Analysis 109
FIG. 50 Key Financials of Zosano Pharma 110
FIG. 51 Valeritas, SWOT Analysis 113
FIG. 52 Key Financials of Valeritas 114
FIG. 53 Valeritas Revenue Split, 2018 115
FIG. 54 3M SWOT Analysis 118
FIG. 55 Key Financials of 3M 118
FIG. 56 3M Revenue Split, 2018 119
FIG. 57 Medtronic Plc SWOT Analysis 122TABLE 1 Global Needle Free Drug Delivery Device Market by Region, 2018-25 (US$ Million) 21
TABLE 2 Guidelines of Using Needle Free Devices 26
TABLE 3 Examples of Prefilled Needle-Free Devices 37
TABLE 4 Global Prefilled Needle-Free Injection System by Region, 2018-25 (US$ Million) 38
TABLE 5 Global Fillable Needle Free Injection System by Region, 2018-25 (US$ Million) 38
TABLE 6 Global Jet Injector Market Size by Region, 2018-25 (US$ Million) 41
TABLE 7 Global Transdermal Drug Delivery Systems, by Region, 2018-25 (US$ Million) 42
TABLE 8 Global Inhaler Technology by Region, 2018-25 (US$ Million) 43
TABLE 9 Global Needle-Free Insulin Delivery Market by Region, 2018-25 (US$ Million) 46
TABLE 10 Global Needle-Free Vaccination Market by Region, 2018-25 (US$ Million) 47
TABLE 11 Global Needle-Free Paediatric Injection Market by Region, 2018-25 (US$ Million) 48
TABLE 12 Global Needle-Free Pain Management Market, by Region, 2018-25 (US$ Million) 49
TABLE 13 Specification of Needle-Free Devices By Injection Methods 51
TABLE 14 Global Needle-Free Powdered Injection Market by Region, 2018-25 (US$ Million) 52….….continued

CONTACT DETAILS :
[email protected]
+44 203 500 2763
+1 62 825 80070
971 0503084105